Can an ARB Help Prevent Migraine Attacks? - Frankly Speaking Ep 479

About this episode

The episode discusses the potential of candesartan as a cost-effective option for preventing migraine attacks.

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-479 Overview: Listen in as we discuss how candesartan, an angiotensin receptor blocker (ARB), may offer a well-tolerated, cost-effective option for migraine attack prevention—even in normotensive patients. Learn to assess benefits, monitor for hypotension, and expand your preventive migraine toolkit with evidence-based insights that may improve adherence and access for patients struggling with traditional therapies. Episode resource links: The Lancet. Neurology. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8. Cephalalgia : An International Journal of Headache. 2023;43(6):3331024231183166. doi:10.1177/03331024231183166. Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

People in this episode

Guest: Robert A. Baldor MD, FAAFP

Topics covered

• migraine prevention
• angiotensin receptor blocker
• candesartan
• evidence-based medicine
• patient adherence

Keywords

• migraine
• candesartan
• ARB
• hypotension
• preventive therapy

Mentioned in this episode

Organizations: Pri-Med

Books & works: The Lancet. Neurology, Cephalalgia : An International Journal of Headache

More episodes of Pri-Med Podcasts

• ADHD Medications Don’t Work the Way We Thought - Frankly Speaking Ep 488 · June 8, 2026 · 14 min
• High Stakes: Primary Care Approaches for Gambling Disorder - Frankly Speaking Ep 487 · June 1, 2026 · 17 min
• Medication Selection and Kidney Protection in Diabetes Management - Frankly Speaking Ep 486 · May 25, 2026 · 14 min
• Sound Check: Preventing Hearing Loss in Teens - Frankly Speaking Ep 485 · May 18, 2026 · 12 min
• Too Good to Be True? The Promises and Risks of Compounded Peptides - Frankly Speaking Ep 484 · May 11, 2026 · 10 min
• One and Done? Comparing Dosing Regimens for HPV Vaccination - Frankly Speaking Ep 483 · May 4, 2026 · 13 min